Armis Advisers’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.04M Buy
76,327
+15,474
+25% +$818K 0.34% 49
2026
Q2
$3.21M Buy
60,853
+2,130
+4% +$112K 0.29% 61
2026
Q1
$3.1M Buy
58,723
+3,931
+7% +$207K 0.3% 59
2025
Q4
$2.88M Buy
54,792
+20,037
+58% +$1.06M 0.32% 54
2025
Q3
$1.84M Buy
34,755
+6,892
+25% +$365K 0.17% 87
2025
Q2
$1.47M Buy
27,863
+4,834
+21% +$255K 0.12% 143
2025
Q1
$1.22M Buy
+23,029
New +$1.22M 0.11% 142

Other funds holding CLOI

Armis Advisers's CLOI Position: Q3 2026 in Review

Armis Advisers increased its VanEck CLO ETF (CLOI) stake by 25% in Q3 2026, buying an estimated $818K and bringing the position to 76,327 shares worth $4.04M. The position accounts for 0.34% of the portfolio, ranked #49.

Armis Advisers first reported a position in CLOI in Q1 2025 and has held it in 7 quarters since. 179 funds tracked by Wall St. Rank hold CLOI as of Q3 2026.

  • Armis Advisers held 76,327 shares of VanEck CLO ETF worth $4.04M as of Q3 2026.
  • Armis Advisers bought 15,474 VanEck CLO ETF shares in Q3 2026, an estimated $818K.
  • VanEck CLO ETF made up 0.34% of Armis Advisers's portfolio in Q3 2026, its #49 holding.
  • Armis Advisers first reported a position in VanEck CLO ETF in Q1 2025 and has held it in 7 quarters since.
  • 179 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.